Hematological Disorders News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Femoral Cannula Market Scope and Opportunities Analysis 2017 ? 2025 - Digital Journal



Femoral Cannula Market Scope and Opportunities Analysis 2017 ? 2025 
Digital Journal
Major factors driving the femoral cannula market include increase in number of patients suffering from chronic conditions such as hypertension, cardio vascular disorders, and other hematological disorders; rise in demand for new and minimally invasive ...

 


Student examines toxicity of shower curtains at Saint Mary's - Observer Online



Student examines toxicity of shower curtains at Saint Mary's 
Observer Online
A study by the Center for Health, Environment and Justice's PVC Campaign showed that PVC curtains give off 10 different volatile organic compounds which, when inhaled, can cause health issues such as cataracts, nervous system depression, liver and ...

 


Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Reiterated by HC Wainwright - StockNewsTimes



StockNewsTimes
 
Rigel Pharmaceuticals (NASDAQ:RIGL) Rating Reiterated by HC Wainwright 
StockNewsTimes
Rigel Pharmaceuticals logo Rigel Pharmaceuticals (NASDAQ:RIGL)'s stock had its ?buy? rating reaffirmed by analysts at HC Wainwright in a research report issued on Friday, February 2nd. They presently have a $7.00 price objective on the biotechnology ...
Rigel Pharmaceuticals, Inc. (RIGL) Given Consensus Rating of ?Buy? by Brokerages The Ledger Gazette
Rigel Pharmaceuticals, Inc. (RIGL) Receives Average Rating of ?Buy? from Analysts The Lincolnian Online
Rigel Pharmaceuticals (RIGL) Downgraded to ?Hold? at BidaskClub ... Dispatch Tribunal
Week Herald  -Marea Informative (blog)  -Enterprise Leader  -Zacks 
all 41 news articles » 


Pragma Pharmaceuticals, LLC Announces the Launch of Decadron - Business Wire (press release)



Business Wire (press release)
 
Pragma Pharmaceuticals, LLC Announces the Launch of Decadron 
Business Wire (press release)
Decadron (dexamethasone tablets, USP) is a first-generation adrenocortical steroid which has a range of indications, including: allergic states, dermatologic states, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic ...

and more » 


3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL? Test for ... - GlobeNewswire (press release)



3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL? Test for ... 
GlobeNewswire (press release)
3DS benefits from twenty years of research, $25M of non-dilutive investment into its platform and more than 130 supporting publications, and holds a portfolio of patents related to three-dimensional telomere analysis for proliferative diseases ...

and more » 


Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease - Labiotech.eu (blog)



Labiotech.eu (blog)
 
Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease 
Labiotech.eu (blog)
Isn't it too early? And, what is the real market potential? Kite and Juno are very young companies, but the buyers are far from stupid: they bought something concrete. I don't believe that Gilead and Celgene, which are among the best-managed companies ...

 


Global Hepatocyte Growth Factor Market- Forecast to 2023 - Chicago Evening Post



Chicago Evening Post
 
Global Hepatocyte Growth Factor Market- Forecast to 2023 
Chicago Evening Post
Albany, NY ? 02/23/2018 ? Scatter Factor which is also known as Hepatocyte Growth Factor is basically a growth of paracrine cellular and morphogenic & motility factor. Hepatocyte growth factor is covered the cells of mesenchymal. It not only acts ...

and more » 


3D Signatures Inc. Announces Changes To Its Board of Directors - GlobeNewswire (press release)



3D Signatures Inc. Announces Changes To Its Board of Directors 
GlobeNewswire (press release)
3DS benefits from twenty years of research, $25M of non-dilutive investment into its platform and more than 130 supporting publications, and holds a portfolio of patents related to three-dimensional telomere analysis for proliferative diseases ...

and more » 


Retinoic Acid Receptor Alpha ? analysis by stage of development, drug target, mechanism of action (MoA), route of ... - The Financial



Retinoic Acid Receptor Alpha ? analysis by stage of development, drug target, mechanism of action (MoA), route of ... 
The Financial
Report covers products from therapy areas Dermatology, Oncology, Respiratory, Central Nervous System, Gastrointestinal, Hematological Disorders, Immunology and Ophthalmology which include indications Acne Vulgaris, Bronchopulmonary Dysplasia ...

 


Neutropenia Market Global Key Players ? Arven Ilac, Lupin Ltd, amd Merck & Co Inc - Industry Today (press release)



WhaTech
 
Neutropenia Market Global Key Players ? Arven Ilac, Lupin Ltd, amd Merck & Co Inc 
Industry Today (press release)
The Neutropenia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
Neutropenia - Companies Involved in Therapeutics Development ... EIN News (press release)

all 6 news articles »